CurrentRheuma coverage · page 43 of 48

Rheumatology (Oxford)

Briefs 1,681–1,720 of 1,905 CurrentRheuma has covered from this journal, newest publication first

Latest from Rheumatology (Oxford)

All coverage, newest first

Rheumatology (Oxford)10 Dec 2022
Systemic lupus erythematosus incidence and prevalence in a large population-based study in northeastern Italy
Cohort studyLupus & APS
Rheumatology (Oxford)10 Dec 2022
Infantile Takayasu: clinical features and long-term outcome
Cohort studyPediatric
Rheumatology (Oxford)8 Dec 2022
A novel estrogen receptor 1: sphingomyelin phosphodiesterase acid-like 3B pathway mediates rituximab response in myositis patients
Mechanistic studyMyositis
Rheumatology (Oxford)8 Dec 2022
The association of trauma with self-reported flares and disease activity in systemic lupus erythematosus (SLE)
Cohort studyLupus & APS
Rheumatology (Oxford)5 Dec 2022
Cumulative disease damage and anti-PM/Scl antibodies are associated with a heavy burden of calcinosis in systemic sclerosis
Cohort studySystemic sclerosis
Rheumatology (Oxford)5 Dec 2022
The natural history of chronic widespread pain in patients with axial spondyloarthritis: a cohort study with clinical and self-tracking data
Cohort studySpondyloarthritis & PsA
Rheumatology (Oxford)2 Dec 2022
Beneficial effects of nintedanib on cardiomyopathy in patients with systemic sclerosis: a pilot study
Cohort studySystemic sclerosis
Rheumatology (Oxford)2 Dec 2022
Crystalline silica exposure in patients with rheumatoid arthritis and systemic sclerosis: a nationwide cross-sectional survey
Cross-sectional studyRA
Rheumatology (Oxford)1 Dec 2022
The top 10 research priorities in psoriatic arthritis: a James Lind Alliance Priority Setting Partnership
Research articleSpondyloarthritis & PsA
Rheumatology (Oxford)29 Nov 2022
Rituximab-treated rheumatic patients: B cells predict seroconversion after COVID-19 boost or revaccination in initial vaccine non-responders
Cohort studyAcross diseases
Rheumatology (Oxford)28 Nov 2022
Prevalence and predictors of atlanto-axial subluxation in rheumatoid arthritis after 12-years’ follow-up (ESPOIR Cohort)
Cohort studyRA
Rheumatology (Oxford)28 Nov 2022
Utility of nailfold capillary assessment for predicting psoriatic arthritis based on a prospective observational cohort study
Cohort studySpondyloarthritis & PsA
Rheumatology (Oxford)28 Nov 2022
Symptomatic myopathies in sarcoidosis: disease spectrum and myxovirus resistance protein A expression
Cohort studyAutoinflammatory & rare
Rheumatology (Oxford)28 Nov 2022
Is the relationship between deprivation and outcomes in rheumatoid arthritis mediated by body mass index? A longitudinal cohort study
Cohort studyRA
Rheumatology (Oxford)28 Nov 2022
Anti-protein arginine deiminase antibodies are distinctly associated with joint and lung involvement in rheumatoid arthritis
Cohort studyRA
Rheumatology (Oxford)28 Nov 2022
High risk of stroke in ANCA-associated vasculitis—a population-based study
Cohort studyVasculitis & PMR
Rheumatology (Oxford)28 Nov 2022
Ocular manifestations of ANCA-associated vasculitis
Cohort studyVasculitis & PMR
Rheumatology (Oxford)23 Nov 2022
Machine learning identifies a profile of inadequate responder to methotrexate in rheumatoid arthritis
Diagnostic or prognostic studyRA
Rheumatology (Oxford)22 Nov 2022
Sex influence on outcomes of patients with systemic sclerosis–associated interstitial lung disease: a EUSTAR database analysis
Cohort studySystemic sclerosis
Rheumatology (Oxford)22 Nov 2022
Disproportionate articular pain is a frequent phenomenon in rheumatoid arthritis and responds to treatment with sarilumab
Secondary analysisRA
Rheumatology (Oxford)22 Nov 2022
Safety and tolerance of vaccines against SARS-CoV-2 infection in systemic lupus erythematosus: results from the COVAD study
Cross-sectional studyLupus & APS
Rheumatology (Oxford)21 Nov 2022
Elevated serum CA72-4 predicts gout flares during urate lowering therapy initiation: a prospective cohort study
Cohort studyGout & crystals
Rheumatology (Oxford)18 Nov 2022
HOXA5 is a key regulator of class 3 semaphorins expression in the synovium of rheumatoid arthritis patients
Mechanistic studyRA
Rheumatology (Oxford)18 Nov 2022
Rheumatoid arthritis macrophages are primed for inflammation and display bioenergetic and functional alterations
Mechanistic studyRA
Rheumatology (Oxford)17 Nov 2022
Microcirculation dynamics in systemic vasculitis: evidence of impaired microvascular response regardless of cardiovascular risk factors
Case-control studyVasculitis & PMR
Rheumatology (Oxford)17 Nov 2022
Methotrexate, leflunomide and tacrolimus use and the progression of rheumatoid arthritis-associated interstitial lung disease
Cohort studyRA
Rheumatology (Oxford)17 Nov 2022
Systemic lupus erythematosus phenotypes formed from machine learning with a specific focus on cognitive impairment
Cross-sectional studyLupus & APS
Rheumatology (Oxford)15 Nov 2022
Association between anti-SSSCA1 antibodies and cancer in systemic sclerosis
Case-control studySystemic sclerosis
Rheumatology (Oxford)15 Nov 2022
Risk factors for lung function decline in systemic sclerosis-associated interstitial lung disease in a large single-centre cohort
Cohort studySystemic sclerosis
Rheumatology (Oxford)12 Nov 2022
Anti-rituximab antibodies demonstrate neutralizing capacity, associate with lower circulating drug levels and earlier relapse in lupus
Cohort studyLupus & APS
Rheumatology (Oxford)12 Nov 2022
TGF-β3 in differentiation and function of Tph-like cells and its relevance to disease activity in patients with systemic lupus erythematosus
Mechanistic studyLupus & APS
Rheumatology (Oxford)10 Nov 2022
Type I interferon and neutrophil transcripts in lupus nephritis renal biopsies: clinical and histopathological associations
Mechanistic studyLupus & APS
Rheumatology (Oxford)10 Nov 2022
Treat-to-target urate-lowering therapy and hospitalizations for gout: results from a nationwide cohort study in England
Cohort studyGout & crystals
Rheumatology (Oxford)9 Nov 2022
Vision transformer assisting rheumatologists in screening for capillaroscopy changes in systemic sclerosis: an artificial intelligence model
Diagnostic or prognostic studySystemic sclerosis
Rheumatology (Oxford)7 Nov 2022
CCL24, CXCL9 and CXCL10 are increased in synovial fluid in patients with juvenile idiopathic arthritis requiring advanced treatment
Cohort studyPediatric
Rheumatology (Oxford)7 Nov 2022
Impact of pregnancy on progression of preclinical autoimmune disorders: a prospective cohort study
Cohort study
Rheumatology (Oxford)4 Nov 2022
Preclinical ocular changes in systemic lupus erythematosus patients by optical coherence tomography
Cross-sectional studyLupus & APS
Rheumatology (Oxford)3 Nov 2022
Changes in anti-MDA5 antibody titres and serum cytokine levels before and after diagnosis of anti-MDA5 antibody-positive dermatomyositis
Cohort studyMyositis
Rheumatology (Oxford)2 Nov 2022
B-cell receptor profiling before and after IVIG monotherapy in newly diagnosed idiopathic inflammatory myopathies
Mechanistic studyMyositis
Rheumatology (Oxford)31 Oct 2022
COVID-19 vaccination in autoimmune diseases (COVAD) study: vaccine safety and tolerance in rheumatoid arthritis
Cross-sectional studyRA

All 1,905 Briefs in ExploreShowing Briefs 1,681–1,720 of 1,905, newest first